We are live on ! Find out more
LFSC icon

F/m Emerald Life Sciences Innovation ETF
LFSC

3 hedge funds and large institutions have $60.6M invested in F/m Emerald Life Sciences Innovation ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

4.68% less ownership

Funds ownership: 91.13% → 86.45% (-4.7%)

89% less capital inflows, than outflows

Capital inflows: $2.67K | Capital outflows: $24.8K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Advisory Services Network
Advisory Services Network
Georgia
+$2.67K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$21K
2
Hunter Associates Investment Management
Hunter Associates Investment Management
Pennsylvania
-$3.85K

LFSC Hedge Fund Activity: Q3 2025 in Review

3 of the 7,650 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q3 2025, worth a combined $60.6M — up 21% from $50.2M a quarter earlier.

Fund positioning in LFSC was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Advisory Services Network, opening a new position worth an estimated $2.67K. The largest seller was UBS Group, exiting entirely with an estimated $21K sold.

  • 3 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $60.6M of F/m Emerald Life Sciences Innovation ETF stock for Q3 2025, up 21% quarter-over-quarter.
  • 1 fund opened new F/m Emerald Life Sciences Innovation ETF positions in Q3 2025 and 1 closed out, a net change of 0 holders.
  • The largest F/m Emerald Life Sciences Innovation ETF buyer in Q3 2025 was Advisory Services Network, an estimated $2.67K added.
  • The largest F/m Emerald Life Sciences Innovation ETF seller in Q3 2025 was UBS Group, an estimated $21K sold.

Based on aggregated 13F filings for Q3 2025.